BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12735485)

  • 1. Intravenous magnesium sulphate in acute myocardial infarction--is the answer "MAGIC"?
    Smetana R; Stühlinger HG; Kiss K; Glogar DH
    Magnes Res; 2003 Mar; 16(1):65-9. PubMed ID: 12735485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnesium in coronary artery disease--is there evidence?].
    Kiss K; Stühlinger HG; Glogar HD; Smetana R
    Wien Med Wochenschr; 2000; 150(15-16):325-9. PubMed ID: 11105327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
    Woods KL; Fletcher S; Roffe C; Haider Y
    Lancet; 1992 Jun; 339(8809):1553-8. PubMed ID: 1351547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnesium sulfate in acute myocardial infarction].
    Balli E; Giomi A; Del Citerna F
    G Ital Cardiol; 1995 Nov; 25(11):1425-32. PubMed ID: 8682239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of magnesium in acute myocardial infarct].
    Beuckelmann DJ
    Z Kardiol; 1996; 85 Suppl 6():129-34. PubMed ID: 9064957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous magnesium sulphate in suspected acute myocardial infarction on acute arrhythmias and long-term outcome.
    Thögersen AM; Johnson O; Wester PO
    Int J Cardiol; 1995 Apr; 49(2):143-51. PubMed ID: 7543083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
    Woods KL; Fletcher S
    Lancet; 1994 Apr; 343(8901):816-9. PubMed ID: 7908076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the magnesium in coronaries (MAGIC) study: A clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarction.
    MAGIC Steering Committee
    Am Heart J; 2000 Jan; 139(1 Pt 1):10-4. PubMed ID: 10618556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a place for magnesium in the treatment of acute myocardial infarction?
    Seelig MS; Elin RJ
    Am Heart J; 1996 Aug; 132(2 Pt 2 Su):471-7; discussion 496-502. PubMed ID: 8694006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravenous magnesium sulphate in acute myocardial infarction.
    Fitzsimmons L; Verderber A; Shively M
    J Cardiovasc Nurs; 1993 Oct; 8(1):80-3. PubMed ID: 8106898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction.
    Roffe C; Fletcher S; Woods KL
    Br Heart J; 1994 Feb; 71(2):141-5. PubMed ID: 8130021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intravenous magnesium administration in acute myocardial infarction.
    Fernandes JS
    Magnes Res; 1994 Dec; 7(3-4):341-3. PubMed ID: 7786697
    [No Abstract]   [Full Text] [Related]  

  • 13. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial.
    Magnesium in Coronaries (MAGIC) Trial Investigators
    Lancet; 2002 Oct; 360(9341):1189-96. PubMed ID: 12401244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does magnesium therapy early in acute MI reduce mortality?
    Phillips J; Krist A
    J Fam Pract; 2003 Mar; 52(3):195, 199. PubMed ID: 12620172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of intravenous administration of SO4Mg in the acute phase of myocardial infarct].
    Pereira D; Pereira TG; Rabaçal C; Carvalho E; Linder J; Afonso JS; Pereira JN; Halpern MJ; Fernandes JS
    Rev Port Cardiol; 1990 Mar; 9(3):205-10. PubMed ID: 2390281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after acute myocardial infarction in patients randomized to treatment with intravenous magnesium or intravenous propranolol in the acute phase.
    Abraham AS; Balkin J; Rosenmann D; Ilan M; Klutstein M; Zion MM
    Magnes Res; 1994 Dec; 7(3-4):273-6. PubMed ID: 7786690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myocardial infarction, reperfusion injury, and intravenous magnesium therapy: basic concepts and clinical implications.
    Steurer G; Yang P; Rao V; Mohl W; Glogar D; Smetana R
    Am Heart J; 1996 Aug; 132(2 Pt 2 Su):478-82; discussion 496-502. PubMed ID: 8694007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium therapy, fibrinolytic parameters and von Willebrand factor in acute myocardial infarction.
    Thögersen AM; Jansson JH; Wester PO
    Int J Cardiol; 1996 Sep; 56(1):53-9. PubMed ID: 8891805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy.
    Raghu C; Peddeswara Rao P; Seshagiri Rao D
    Int J Cardiol; 1999 Dec; 71(3):209-15. PubMed ID: 10636525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnesium therapy in acute myocardial infarction. New points of view].
    Landmark K; Abdelnoor M
    Tidsskr Nor Laegeforen; 1995 Aug; 115(18):2268-70. PubMed ID: 7652726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.